Related Experiment Videos
5,5-Diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitors
1NPS Pharmaceuticals Inc., 6850 Goreway Drive, L4V 1V7, Mississauga, ON, Canada. misaac@npsallelix.com
Bioorganic & Medicinal Chemistry Letters
|May 30, 2001
Abstract:
A novel series of 5,5-diaryl-2-amino-4-pentenoates was synthesized and found to be potent and selective glycine transporter type-2 reuptake inhibitors.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Exploring the diagnostic and prognostic utility of resting state functional MRI connectivity in acute/sub-acute TBI.
medRxiv : the preprint server for health sciences·2025
Influence of amino acid sequence in a peptidic Cu+-responsive luminescent probe inspired by the copper chaperone CusF.
Organic & biomolecular chemistry·2018
Applying the QUARTZ Trial Results in Clinical Practice: Development of a Prognostic Model Predicting Poor Outcomes for Non-small Cell Lung Cancers with Brain Metastases.
Clinical oncology (Royal College of Radiologists (Great Britain))·2018
EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.
The journal of prevention of Alzheimer's disease·2017
Pronator teres accessorius: A new variant in flexor antebrachial musculature.
Morphologie : bulletin de l'Association des anatomistes·2017
Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells.
Bioorganic & medicinal chemistry letters·2026
Quinolin(on)es and pyridin(on)es as promising scaffolds against mycobacterial infections.
Bioorganic & medicinal chemistry letters·2026
Amyloid-β aggregation inhibitory activity and neuroprotective effects of metabolites of Trichoderma pluripenicillatum.
Bioorganic & medicinal chemistry letters·2026
Electrophilic aromatic halogenation of perylenequinones: a strategy to improve photodynamic properties.
Bioorganic & medicinal chemistry letters·2026
Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.
Bioorganic & medicinal chemistry letters·2026
Methods of predicting clinically significant DRUG-DRUG interactions beyond validated interaction checkers.
Expert opinion on drug metabolism & toxicology·2026
Cholinesterase Inhibitors in Alzheimer's Disease: Medicinal Chemistry, Mechanistic Insights, and Emerging Multitarget Strategies.
CNS & neurological disorders drug targets·2026
Discovery of a Caffeic Acid Thioamide with Potent Activity against Pathogenic Fungi and Fluconazole Tolerance-Eliminating Effects in Candida albicans.
Drug design, development and therapy·2026